But at a time when we should be promoting health care access, the health plan for New York City employees recently made a surprising decision with far-reaching repercussions: they announced that they will discontinue coverage of GLP-1 weight loss medicines for its 400,000 public employees
It works by mimicking a naturally occurring hormone that helps regulate blood sugar levels, slows stomach emptying, and acts on brain receptors to reduce appetite and increase feelings of fullness
Comparing allodynia risk across GLP-1 medications As the GLP-1 medication landscape continues to expand, understanding the relative allodynia risk across different agents becomes increasingly relevant
In Connecticut, semaglutide injections can be given by professionals with the titles MD, DO, NP, APRN, PA, RN, or LPN